Telomir Pharmaceuticals, Inc. share price logo

Telomir Pharmaceuticals, Inc.

NASDAQ: TELO

$1.19

+0.02

(+1.71%)

as on

Telomir Pharmaceuticals, Inc. Stock Performance

as on August 28, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.15
    $1.20
    downward going graph

    3.36%

    Downside

    0.84%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.89
    $2.09
    downward going graph

    25.34%

    Downside

    75.71%

    Upside

    downward going graph

Telomir Pharmaceuticals, Inc. share price movements today

Previous Close
$1.17
Open
$1.19
Volume
790.4K
Market Cap
$81.2M
Day's Low - High
$1.15 - $1.20
52 Week Low - High
$0.89 - $2.09

Telomir Pharmaceuticals, Inc. Historical Returns

1 Month Return
-4.88 %
3 Month Return
-9.3 %
1 Year Return
-20.95 %
3 Year Return
0 %
5 Year Return
0 %

Telomir Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Telomir Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$81.2M

EPS (TTM)

-0.914

Dividend Yield

0.00%

PE Ratio (TTM)

-1.29

Industry PE ratio

-1.5979841897233202

PEG Ratio

0.004498154496951927

Return On Equity TTM

-102.69%

Telomir Pharmaceuticals, Inc. Stock Valuation

Track how Telomir Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Telomir Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-1500.52x)

December 31, 2021

Today (-4.03x)

December 31, 2025

Industry (-1.60x)

December 31, 2025

Highest (-4.03x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.03x

Telomir Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Telomir Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$81.2MNA-1.290.00%NA
BUY$45.3B655.66%NA0.00%NA
BUY$140.1B173.75%31.9286.04%NA
BUY$63.4B-60.84%-7.98-12.57%NA
BUY$85.3B22.84%19.984.86%0.44%

Stock Returns calculator for Telomir Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Telomir Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Telomir Pharmaceuticals, Inc. investment value today

Current value as on today

₹87,623

Returns

-₹12,377

(-12.38%)

Returns from Telomir Pharmaceuticals, Inc. Stock

-₹19,595 (-19.59%)

Dollar Impact

₹7,218 (+7.22%)

Indian Investors' Interest in Telomir Pharmaceuticals, Inc. Stock

Search interest for Telomir Pharmaceuticals, Inc. Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-64% versus previous 30 day period

Telomir Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
-1
-6
-2
-2
-5
-1
-2
-1
-1
EBITDA
-
-1
-5
-2
-2
-5
-1
-2
0
-1
Interest Expense
4
-
-
-
-
0
0
-
0
0
Depreciation
1
0
-
-
-
-
-
-
-
-
Income Before Tax
-6
-1
-5
-2
-2
-5
-1
-2
0
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-6
-1
-5
-2
-2
-5
-1
-2
0
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Telomir Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
0
0
-3
-12
-10
EBITDA
-
-
-11
0
-10
Interest Expense
-
-
1
-4
-
Depreciation
0
0
-
12
-
Income Before Tax
0
0
-13
-16
-10
Income Tax Expense
-
-
-
-
-
Net Income
0
0
-13
-16
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Telomir Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-1
-5
-2
-2
-5
-1
-2
0
-1
Operating Cash Flow
-1
-1
-1
0
0
0
0
-1
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
5
0
0
1
-
1
7
1
0
0
Change in Cash
3
-1
-1
0
0
0
6
0
-1
0

Telomir Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-13
-16
-10
Operating Cash Flow
0
0
-3
-5
-3
Investing Cash Flow
-
-
-
-
-
Financing Cash Flow
0
0
3
6
9
Change in Cash
-
0
0
1
6

Mutual Funds that own Telomir Pharmaceuticals, Inc. Stock

Check out the Mutual Funds with significant holdings in Telomir Pharmaceuticals, Inc..

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.447289%
995373
Fidelity Concord Street Trust
0.270016%
185704
John Hancock Variable Insurance Trust
0.001472%
1013
ProFunds
0.0001%
69

Global Institutional Holdings in Telomir Pharmaceuticals, Inc.

Funds
Holdings
Vanguard
2.32%
Donald R. Jowdy
0.07%
iShares
0.05%

Insights on Telomir Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TELO stock has moved up by 5.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 483.4% return, outperforming this stock by 503.0%

About Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
OrganisationTelomir Pharmaceuticals, Inc.
Headquarters100 SE 2nd Street, Miami, FL, United States, 33131
IndustryBiotechnology
CEOMr. Erez Aminov
E-voting on sharesClick here to vote

Key Management of Telomir Pharmaceuticals, Inc.

Name

Title

Mr. Erez Aminov

Chairman of the Board & CEO

Mr. Andriy Mushak C.P.A.

Chief Financial Officer

Dr. Itzchak Angel Ph.D.

Chief Scientific Advisor

FAQs

What is Telomir Pharmaceuticals, Inc. share price today?

Telomir Pharmaceuticals, Inc. share price today is $1.19 as on at the close of the market. Telomir Pharmaceuticals, Inc. share today touched a day high of $1.20 and a low of $1.15.

What is the 52 week high and 52 week low for Telomir Pharmaceuticals, Inc. share?

Telomir Pharmaceuticals, Inc. share touched a 52 week high of $2.09 on and a 52 week low of $0.89 on . Telomir Pharmaceuticals, Inc. stock price today i.e. is closed at $1.19,which is 43.09% down from its 52 week high and 33.93% up from its 52 week low.

What is Telomir Pharmaceuticals, Inc.'s market capitalisation today?

Telomir Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Telomir Pharmaceuticals, Inc. Stock (TELO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Telomir Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telomir Pharmaceuticals, Inc. Shares that will get you 1.2605 shares as per Telomir Pharmaceuticals, Inc. share price of $1.19 per share as on August 28, 2026 at 8:45 am IST.

What is the minimum amount required to buy Telomir Pharmaceuticals, Inc. Stock (TELO) from India?

Indian investors can start investing in Telomir Pharmaceuticals, Inc. (TELO) shares with as little as ₹95.53 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.30 in Telomir Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Telomir Pharmaceuticals, Inc. share’s latest price of $1.19 as on August 28, 2026 at 8:45 am IST, you will get 8.4034 shares of Telomir Pharmaceuticals, Inc.. Learn more about fractional shares .